Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 23,640 shares at $8.07 ($192K) on 2023-08-21, disclosed to the SEC on 2023-08-21.
Scheduled sale ($192k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 772 | $7K | 3.4% |
| 2 | $8.46 | 2,868 | $24K | 12.6% |
| 3 | $8.07 | 20,000 | $161K | 84.0% |
| Total | $8.13 avg | 23,640 | $192K | 100% |
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |